Platform measuring how molecules and materials behave, building an empirical data layer for AI and pharma.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Funding round Apoha raised $36M led by Singular to commercialise its platform that generates empirical molecular behaviour data, already used by Boehringer Ingelheim. | $36M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.